|
Market Cap (1-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.084 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 4 May 2023, 16:39. The announcement is not marked as price sensitive, and is 15 page(s) in length and 284.83kb in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.006% short sold according to ASIC data. It was ranked the 590th most shorted stock on the ASX. It remains ranked 590th as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| Change of Director's Interest Notices | 4 May 2023, 16:39 |
| Notification of cessation of securities - IBX | 2 May 2023, 10:54 |
| Imagion initiates leadership restructuring plan | 28 April 2023, 10:16 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:28 |
You must be logged in to post a reply.
Imagion Biosystems 